Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

Page 31 of 100

  • fortune logo icon (red)Health

    Summer Friday: Brainstorm Health

    By
  • Biotech bad dayHealth

    About Biopharma’s Ridiculously Bad Day: Brainstorm Health

    By
  • CVS earnings beatHealth

    CVS Is Demolishing Wall Street Expectations. Here’s What That Means: Brainstorm Health

    By
  • Novartis Zolgensma FDAHealth

    Novartis Defends $2.1 Million Gene Therapy After FDA Data Manipulation Claims—Brainstorm Health

    By
  • fortune logo icon (red)Commentary

    CVS Takes on Amazon With CarePass: Brainstorm Health

    By
  • fortune logo icon (red)Commentary

    Failure Is Built Into Pharma. But It’s Complicated: Brainstorm Health

    By
  • Livongo IPO deviceHealth

    Digital Health Firm Livongo’s Secret Sauce? Employees Who Are Actually Patients

    By
  • Trump HHS drug reimportationHealth

    Can Canada Help Fix America’s High Drug Price Problem?—Brainstorm Health

    By
  • fortune logo icon (red)Commentary

    Legislating Social Media Addiction: Brainstorm Health

    By
  • Amazon PillPack SurescriptsCommentary

    Surescripts Throws Down the Gauntlet in Amazon PillPack Spat: Brainstorm Health

    By
  • fortune logo icon (red)Commentary

    Blindness, Edited Away: Brainstorm Health

    By
  • Reshma Kewalramani CEO VertexCommentary

    A $43 Billion Biotech Now Has a Female CEO: Brainstorm Health

    By
  • CVS Aetna Social Determinants of HealthHealth

    How CVS Wants to Link Social Care With Health Care: Brainstorm Health

    By
  • fortune logo icon (red)Health

    An Arm Implant to Block HIV: Brainstorm Health

    By
  • Health public goodHealth

    Health Care on the Global 500: Brainstorm Health

    By